Challenges in lung cancer therapy during the COVID-19 pandemic

Souquet déclare avoir des liens d’intérêts avec Amgen, Astellas, Astex, AstraZeneca, BMS, Bayer, Boehringer  Ingelheim, Chugai, Lilly, Novartis, Pfizer, Pierre Fabre Onco, Roche,

Dr Leiter has received research funding from, has provided continuing medical education on behalf of, or has acted as a consultant to AstraZeneca, Boehringer Ingelheim,

The first, an early pandemic scenario of risk mitigation, is characterized by an altered risk–benefit ratio of radiotherapy for lung cancer patients due to their

3 Si vous devez vous rendre dans une de ces zones endémiques, votre neurologue étudiera avec vous la nécessité ou non de vous vacciner contre la fièvre

risk evaluation: identification and quantification of the baseline risk of transmission of SARS-CoV-2 and strain on the health system’s capacity associated with the gathering

systems to meet both surveillance objectives and other public health objectives, including monitoring and assessing the burden and impact of influenza-associated disease and

The agricultural trade balance of Latin America and the Caribbean (15 countries, with available data to July 2020) increased by a value of 9.72 billion dollars, or 13 percent,

- Christophe Hézode has been a clinical investigator, speaker and/or consultant for Abbvie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen